1Ma, J, Folsom, AR, Shahar, E & Eckfeldt, JH (1995) Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Clin Nutr 62, 564–571.
2Zock, PL, Mensink, RP, Harryvan, J, de Vries, JH & Katan, MB (1997) Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. Am J Epidemiol 145, 1114–1122.
3Vessby, B, Gustafsson, IB, Tengblad, S, Boberg, M & Andersson, A (2002) Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci 967, 183–195.
4Vessby, B, Tengblad, S & Lithell, H (1994) Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37, 1044–1050.
5Sundstrom, J, Lind, L, Vessby, B, Andren, B, Aro, A & Lithell, H (2001) Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 103, 836–841.
6Ohrvall, M, Berglund, L, Salminen, I, Lithell, H, Aro, A & Vessby, B (1996) The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men : 19 years follow-up. Atherosclerosis 127, 65–71.
7Warensjo, E, Riserus, U & Vessby, B (2005) Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48, 1999–2005.
8Haffner, SM (2003) Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol 92, 18J–26J.
9Blake, GJ & Ridker, PM (2002) Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252, 283–294.
10Calder, PC (2006) n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S–1519S.
11Fernandez-Real, JM, Broch, M, Vendrell, J & Ricart, W (2003) Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 26, 1362–1368.
12Klein-Platat, C, Drai, J, Oujaa, M, Schlienger, JL & Simon, C (2005) Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 82, 1178–1184.
13Ferrucci, L, Cherubini, A, Bandinelli, S, Bartali, B, Corsi, A, Lauretani, F, Martin, A, Andres-Lacueva, C, Senin, U & Guralnik, JM (2006) Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91, 439–446.
14Skarfors, ET, Selinus, KI & Lithell, HO (1991) Risk factors for developing non-insulin dependent diabetes : a 10 year follow up of men in Uppsala. BMJ 303, 755–760.
15Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF & Turner, RC (1985) Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
16Boberg, M, Croon, LB, Gustafsson, IB & Vessby, B (1985) Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci (Lond) 68, 581–587.
17DeFronzo, RA, Tobin, JD & Andres, R (1979) Glucose clamp technique : a method for quantifying insulin secretion and resistance. Am J Physiol 237, E214–E223.
18Liu, G, Lynch, JK, Freeman, J, et al. (2007) Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors. J Med Chem 50, 3086–3100.
19Ntambi, JM, Miyazaki, M, Stoehr, JP, Lan, H, Kendziorski, CM, Yandell, BS, Song, Y, Cohen, P, Friedman, JM & Attie, AD (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 99, 11482–11486.
20Sampath, H, Miyazaki, M, Dobrzyn, A & Ntambi, JM (2007) Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem 282, 2483–2493.
21Riserus, U, Arnlov, J & Berglund, L (2007) 30, 2928–2933.
22Weigert, C, Brodbeck, K, Staiger, H, Kausch, C, Machicao, F, Haring, HU & Schleicher, ED (2004) Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. J Biol Chem 279, 23942–23952.
23Ajuwon, KM & Spurlock, ME (2005) Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 135, 1841–1846.
24Balk, EM, Lichtenstein, AH, Chung, M, Kupelnick, B, Chew, P & Lau, J (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk : a systematic review. Atherosclerosis 189, 19–30.
25Riserus, U, Tan, GD, Fielding, BA, Neville, MJ, Currie, J, Savage, DB, Chatterjee, VK, Frayn, KN, O'Rahilly, S & Karpe, F (2005) Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans : link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. Diabetes 54, 1379–1384.
26Attie, AD, Krauss, RM, Gray-Keller, MP, et al. (2002) Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 43, 1899–1907.